Anti-MOG is a recently discovered condition that co-occurs with other demyelinating conditions. To learn more about this condition, John and Ryan speak with Lana Harder, Ph.D., ABPP-CN, who is a founding member and current Co-Director of the Children’s Medical Center Pediatric Demyelinating Disease Clinic.
• Anti-MOG history/discovery
• Comorbidity between anti-MOG and other demyelinating conditions
• Clinical symptoms
• Medical treatments
• Tips for conducting neuropsychological evaluations in children with this condition
Dr. Lana Harder is a board-certified clinical neuropsychologist and pediatric neuropsychologist. She is the Manager of Neuropsychology Service and Neuropsychology Training Director at Children’s Medical Center Dallas. She holds dual faculty appointments as Associate Professor of Psychiatry and Neurology at University of Texas Southwestern. Additionally, she was elected to the Board of Directors of the American Board of Clinical Neuropsychology (ABCN) and the Association of Postdoctoral Programs in Clinical Neuropsychology (APPCN). She is also a Clinical Neuropsychology Ambassador to the American Board of Professional Psychology Early Career Psychologist Task Force.
Narayan, R., Simpson, A., Fritsche, K., Salama, S., Pardo, S., Mealy, M., … & Levy, M. (2018). MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Multiple sclerosis and related disorders, 25, 66-72.